Trexquant Investment LP - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$359,596
+43.8%
14,952
+83.1%
0.01%
+28.6%
Q1 2023$249,982
+24.4%
8,164
+58.9%
0.01%
+16.7%
Q4 2022$200,986
-81.0%
5,139
-76.9%
0.01%
-83.8%
Q3 2022$1,059,000
-52.6%
22,234
-61.5%
0.04%
-63.0%
Q2 2022$2,233,000
+80.2%
57,677
+166.7%
0.10%
+72.4%
Q1 2022$1,239,000
+3.2%
21,627
+56.7%
0.06%
-38.9%
Q3 2021$1,201,000
+42.6%
13,803
+110.9%
0.10%
+33.8%
Q2 2021$842,000
-41.2%
6,544
-63.4%
0.07%
-45.8%
Q1 2021$1,431,000
+102.1%
17,878
+106.2%
0.13%
+74.7%
Q4 2020$708,0008,6690.08%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders